Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)

Our findings suggested that women with colon cancer are more likely to have worse chemotherapy completion rates and more severe adverse events, but they have better survival. Sex as a biological variable warrants further consideration in chemotherapy administration and survivorship management after colon cancer diagnosis.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2025-09-20
DOI
https://doi.org/10.1093/jnci/djaf281
Citations
2
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
2.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)

Chaoyuan Kuang, Smitha Krishnamurthi, Jeffrey A. Meyerhardt, Chao Ma et al.
2 citations
JNCI Journal of the National Cancer Institute
Colorectal Cancer Treatments and Studies
2.09
article

Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)

Chaoyuan Kuang, Smitha Krishnamurthi, Jeffrey A. Meyerhardt, Chao Ma, Ardaman Shergill, En Cheng, Qian Shi, Benjamin Kye Jyn Tan, Justin C. Brown, Thomas E. Rohan, Anthony F. Shields, Eileen Mary O'Reilly, Kimmie Ng, Xiaonan Xue, Pankaj Kumar, J. Philip Kuebler
article en
2 citations

Abstract

Our findings suggested that women with colon cancer are more likely to have worse chemotherapy completion rates and more severe adverse events, but they have better survival. Sex as a biological variable warrants further consideration in chemotherapy administration and survivorship management after colon cancer diagnosis.

JNCI Journal of the National Cancer InstituteVol. 117(12)
Albert Einstein College of Medicine (US), Cleveland Clinic (US), Mayo Clinic (US), Memorial Sloan Kettering Cancer Center (US), Montefiore Medical Center (US), Wayne State University (US), Washington University in St. Louis (US), Cornell University (US), Alliance for Clinical Trials in Oncology (US), University of Chicago (US), Florida Hospital Cancer Institute (US), The Barbara Ann Karmanos Cancer Institute (US), Dana-Farber Cancer Institute (US), Hôtel-Dieu de Québec (CA), Mayo Clinic in Arizona (US), Alliance Data (United States) (US), Illinois CancerCare (US), Columbus Community Clinical Oncology Program (US)
Openalex Percentile: Top 10%
Colorectal Cancer Treatments and Studies
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.